EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Qing Ye
Marko Turina
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ye, Q.
Right arrow Articles by Turina, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ye, Q.
Right arrow Articles by Turina, M.

Eur J Cardiothorac Surg 2000;17:587-591
© 2000 Elsevier Science NL

Fibrin gel as a three dimensional matrix in cardiovascular tissue engineering

Qing Yea, Gregor Zünda, Peter Benedikta, Stefan Jockenhoevela, Simon P. Hoerstrupa, Shelly Sakyamab, Jeffrey A. Hubbellb, Marko Turinaa

a Clinic for Cardiovascular Surgery, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
b Department of Materials and Institute for Biomedical Engineering, ETH-Zurich, Switzerland

Corresponding author. Tel.: +41-1-255-38-01; fax: +41-1-255-43-69
e-mail: gregor.zund{at}chi.usz.ch

Objective: In tissue engineering, three-dimensional biodegradable scaffolds are generally used as a basic structure for cell anchorage, cell proliferation and cell differentiation. The currently used biodegradable scaffolds in cardiovascular tissue engineering are potentially immunogenic, they show toxic degradation and inflammatory reactions. The aim of this study is to establish a new three-dimensional cell culture system within cells achieve uniform distribution and quick tissue development and with no toxic degradation or inflammatory reactions. Methods: Human aortic tissue is harvested from the ascending aorta in the operation room and worked up to pure human myofibroblasts cultures. These human myofibroblasts cultures are suspended in fibrinogen solution and seeded into 6-well culture plates for cell development for 4 weeks and supplemented with different concentrations of aprotinin. Hydroxyproline assay and histological studies were performed to evaluate the tissue development in these fibrin gel structures. Results: The light microscopy and the transmission electron microscopy studies for tissue development based on the three-dimensional fibrin gel structures showed homogenous cell growth and confluent collagen production. No toxic degradation or inflammatory reactions could be detected. Furthermore, fibrin gel myofibroblasts structures dissolved within 2 days in medium without aprotinin, but medium supplemented with higher concentration of aprotinin retained the three-dimensional structure and had a higher collagen content (P<0.005) and a better tissue development. Conclusions: A three-dimensional fibrin gel structure can serve as a useful scaffold for tissue engineering with controlled degradation, excellent seeding effects and good tissue development.

Key Words: Tissue engineering • Scaffold • Fibrin gel • Cardiovascular




This article has been cited by other articles:


Home page
Biophys. JHome page
J. V. Nauman, P. G. Campbell, F. Lanni, and J. L. Anderson
Diffusion of Insulin-Like Growth Factor-I and Ribonuclease through Fibrin Gels
Biophys. J., June 15, 2007; 92(12): 4444 - 4450.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
T. Hasegawa, K. Okada, Y. Takano, Y. Hiraishi, and Y. Okita
Autologous fibrin-coated small-caliber vascular prostheses improve antithrombogenicity by reducing immunologic response
J. Thorac. Cardiovasc. Surg., May 1, 2007; 133(5): 1268 - 1276.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
C. Jux, H. Bertram, P. Wohlsein, M. Brugmann, P. Wuboldt, C. Fink, T. Paul, and G. Hausdorf
Experimental ASD closure using autologous cell-seeded interventional closure devices
Cardiovasc Res, January 1, 2002; 53(1): 181 - 191.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
S. Jockenhoevel, G. Zund, S. P. Hoerstrup, K. Chalabi, J. S. Sachweh, L. Demircan, B. J. Messmer, and M. Turina
Fibrin gel - advantages of a new scaffold in cardiovascular tissue engineering
Eur. J. Cardiothorac. Surg., April 1, 2001; 19(4): 424 - 430.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2000 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.